{"name":"co.don AG","slug":"co-don-ag","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"co.don chondrosphere®","genericName":"co.don chondrosphere®","slug":"co-don-chondrosphere","indication":"Repair of cartilage defects in the knee","status":"phase_3"}]}],"pipeline":[{"name":"co.don chondrosphere®","genericName":"co.don chondrosphere®","slug":"co-don-chondrosphere","phase":"phase_3","mechanism":"co.don chondrosphere is a cell-based therapy that utilizes autologous chondrocytes to repair cartilage defects.","indications":["Repair of cartilage defects in the knee"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNTTRsT3g5Sk9ILVNoVDR1WjRQZHdzU2c1dHFBMlpIUHZRYkdHNzJEWERxV3hxNW9TcUlzbEtwTWdHT1lOUXoyYmxNUWVUbVRQZ0RTbHZiZEFwZ0J2RDg3c3dBZ09RYldrb1lZNkxNNWFPdXAtYUZGblFXWXJXRjgyMWptVDIzS1JSTkhaVVJGSXE4TUVfLXNldDlPLXVWTGxxa21ocnpvQkFqNk1fLXpTNHRqcDJrQ094VjlILVR1T2w?oc=5","date":"2026-01-07","type":"pipeline","source":"Fierce Pharma","summary":"Bayer files separate lawsuits against Moderna, J&J and Pfizer-BioNTech over COVID vaccine tech - Fierce Pharma","headline":"Bayer files separate lawsuits against Moderna, J&J and Pfizer-BioNTech over COVID vaccine tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQRTZmdTNVd1M5c1F0aVJ3UERVbmROU2tQaEIwZHlKUU9XX2dBSmF4S2FRa3N1dDdFYUxSX0M0RjdHTmZhdzlCMEhoT2NTZVp5ZXRWMWlNZ1FHZFNsR3NGMGRyd0s5WU5MZEs0VmpHTGxiV04tTXlqMmdGcnE2ZTVQR201OHdUTmp1RG9tTzRkN01FaXVPS1h5MmxNNjB0cUNMUWNnZ01EdnNvMjlLSlJr?oc=5","date":"2026-01-07","type":"patent","source":"Il Sole 24 ORE","summary":"Bayer reopens patent war on Covid vaccines: lawsuits against big boys over mrna technology start - Il Sole 24 ORE","headline":"Bayer reopens patent war on Covid vaccines: lawsuits against big boys over mrna technology start - Il Sole 24 ORE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTFBYVVRRdHp5SmNQa2xPa1pTbnFFLThrdUFRUzlGNS1HeUp4azRjSV9LUmNDWEo0QUlaa2s5MVYxY0dTSk1ROWVkRjJKNlVpeVNEQXdrZXJCOWx4RHlzLUFVQzNNVjHSAWpBVV95cUxQSW5NWDZHMzZKMDNZNXkzUmd4QUpBbU1rbkFMbWNJRi02dFdxcVQtc3F2ckI1bE1lcHVTV25iZGEzbHBIYk1iTk1fU21kbHoyZ0Z2eWNHMmQtZFBQWHgzTS1VY19xemEzaFR3?oc=5","date":"2025-06-24","type":"regulatory","source":"BioInformant","summary":"The New CO.DON Plant for the EU-approved Advanced Therapy Cartilage Regeneration Treatment Sets a Milestone in Cell Therapy for Commercial Manufacturing - BioInformant","headline":"The New CO.DON Plant for the EU-approved Advanced Therapy Cartilage Regeneration Treatment Sets a Milestone in Cell Ther","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQbnhjemFSVi04cjRGY3Y1dXhpUXRCaDZNTE5qcExvNWhrZ0M0OXVKVFItZy16TURma19GSVFhWVAtYmk5NkxKbmdCZm9SUTRkV0NtYXhjQjZ6TUJrakw1eGdYQ2xLMHROczVuUDBhYzI0SF9JcTFTWUFpQllqY1M2dU8wVW1qV2xXaHRreVRPbnNmamVVcDVxa0hVTFVnVzhwN2xZdnk0UQ?oc=5","date":"2024-06-11","type":"deal","source":"BioWorld News","summary":"Lotus acquires Teva Thailand to build Southeast Asian footprint - BioWorld News","headline":"Lotus acquires Teva Thailand to build Southeast Asian footprint","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTFBkRFh3RGNTYkltaFZiZmp5Ry0wSFA5SVhIb1VJdU9uYXFQVlEwWWlQQ3BIVG1QaDJwa1hkM0t0WFl5Tzh6YXF4T1Noc1BTSWwxX1BvUnZpOXFTdE10RTBKb3FpTVI?oc=5","date":"2024-04-05","type":"pipeline","source":"Britannica","summary":"Eli Lilly and Company - Britannica","headline":"Eli Lilly and Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5vS2dEWDRKSGV0WGFMQ2djZG9ka3lnd2M1RENtUkEwRmVINENLSHI5NjEtS3h6dVp4SnBldDI5MWpidWEtNEZQSm1FbXJiWC1jcUlwVUt2VEpnQ25tX3M1bDM1WV83cFnSAWxBVV95cUxOSFNFejlEdTJ5S3hqdENfTTZIRFV6SVFVWkN6U3hLd2JETlBHcTUyY3RhZ3JheWh4WmVSTkM1OE82V3g3RVVUaW54amU0WFhudk1ZaFRmR3VHY2dLVG9KeTdZdE5IWHdyb0dSbUY?oc=5","date":"2023-11-28","type":"regulatory","source":"BioInformant","summary":"Pricing Of Approved Cell Therapy Products - BioInformant","headline":"Pricing Of Approved Cell Therapy Products","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxORGd0ZTY3Skc2TFhwZFhvbzBabnY4YUJTVXJMcmRxZGQ3bW5ubkUzT0syY09UQ0o3QlZkYzlMZWJoOGZvNWxNa0xfd2cyeFFjV1JWNl9meWl1OVBybUlObTNQS2ZKSnNqUFRSVU5VUVJlV1lJUWVVeC1zZnI1LXhOV2d6b1FkZEVHZFhCWnRCNmxWc0N1NEozY1NsT1F5amtjN1hNQzBGNTlQYzE5U01PcldPTFNlaUtNMk5WbzFFaXU3RjFtdEFRUzhLNmlOZEt0X0l0bzJEakRlbWx5LTF0ZUNSend6bUxodlB4bVlyYVBKNTBlWEdlSkJzWVVrc2lsRmw1VmlIOWNDU1l3M2dvY3dlc29HelVjTTVPVXVfcDBCdUQ5UUxXaU1TdEV6ZjZTNzZYeXM0UEVWcEstdGwyTmd0cXpfVWVIak5oQU40ZkE?oc=5","date":"2023-01-25","type":"pipeline","source":"PR Newswire","summary":"ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Leader in Regenerative Therapies - PR Newswire","headline":"ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Amb","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQdEZ0R0NnX1kxWHNqWjVEdm5fQjFZbEZHeEtGUXJCazJNcFB5YWc1NW9ZYWpheXd6aU1CY3FBSkFkcjVsZmVtRnpCcnhxUXg4REhjb1RPQmY3SmphOHJIWjZVN0xvVEM4cTgzQWdWREF3ZldMYjhlUkVvNUNLQmRleVZxZ0I?oc=5","date":"2022-05-10","type":"pipeline","source":"pharmaphorum","summary":"Healthcare communication and how it’s changing - pharmaphorum","headline":"Healthcare communication and how it’s changing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPRExhdW0tTk82Q2ljV01FUEZaaVpkRHN6TnlsV2tOVFlaX0pVYTl3RHc2eEw4RUpTQmxiNHlsNHBYOVFoNWdraVl1c0JvaTVSeDc3MkVtaGxNbTBSSE5pR3h0dEhndFhZQzNJY1pBN3AtU2MtSjNpV0l4emFMQnlVWGRpVEhYSl9Fd2c2c0xDTHhJWTV0VlBLOEVEMUxSMS01SUgyaTZDZk9nT2lhWjRqQlZJUlhwRjhra2Jma3YwdHdSOEM4clY1TUJLY1Y4Qk51dkRHbmpQZUNoTjllNlpHUA?oc=5","date":"2021-05-06","type":"pipeline","source":"PR Newswire UK","summary":"EVERSANA™ strengthens global market access and pricing leadership in European expansion - PR Newswire UK","headline":"EVERSANA™ strengthens global market access and pricing leadership in European expansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE11M080dGw4OUh4d1VLbG5OR0JiVVA3eXdQYXU3dGJJMEpRLXdZT2dtZHZyV3hOcUdydnBYaTkzNm1tdTgyeGdfMDVxYjdENmNudFVLa0dESkxRcHB6bm04?oc=5","date":"2018-03-01","type":"pipeline","source":"Nature","summary":"Elongator and codon bias regulate protein levels in mammalian peripheral neurons - Nature","headline":"Elongator and codon bias regulate protein levels in mammalian peripheral neurons","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}